• OPEN AN ACCOUNT
Indian Indices
Sensex
82,814.71 316.57
( 0.38%)
Global Indices
Nasdaq
49,649.56 233.39
(0.47%)
Dow Jones
6,930.29 47.40
(0.69%)
Hang Seng
56,838.27 -629.56
(-1.10%)
Nikkei 225
10,691.66 64.62
(0.61%)
Forex
USD-INR
91.03 0.34
(0.37%)
EUR-INR
107.23 0.00
(0.00%)
GBP-INR
122.67 -0.16
(-0.13%)
JPY-INR
0.59 0.00
(-0.25%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5329749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
210.31
46.94
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

Hindustan Construction Company update on proposed rights issue
Dec 02,2025

Hindustan Construction Company announced the terms of rights issue as under:

  • Total number of Rights Equity Shares and Rights Issue size: 79,99,91 ,900 Rights Equity Shares each for an amount aggregating to Rs. 999.99 Crore (assuming full subscription).
  • Rights Issue Price: Rs.12.50 per Rights Equity Share (including a premium of Rs. 11.50 per Rights Equity Share) payable on application
  • Rights entitlement ratio: The Rights Equity Shares are being offered on a Rights basis to Eligible Equity Shareholders in the ratio of 277 Rights Equity Shares for every 630 fully paid-up Equity Shares held on the record date.
  • Record date: Friday December 5, 2025 for determining the shareholders eligible to apply for the equity shares in the Rights Issue.

Rights Issue period:

  • Rights Issue Opening Date: Friday, December 12, 2025
  • Last Date for On Market Renunciation of Rights Entitlements: Wednesday, December 17, 2025
  • Last Date for Off Market Renunciation: Friday, December 19, 2025
  • Rights Issue Closing Date: Monday, December 22, 2025

Outstanding Equity Shares:

  • Prior to the Rights Issue: 1,81 ,94,76,162 Equity Shares of the Company;
  • Post Rights Issue: 2,61 ,94,68,062 Equity Shares of the Company